Diartis Pharmaceuticals


Diartis Pharmaceuticals, Inc. is a privately held biopharmaceutical company with headquarters in Mountain View, CA. Diartis Pharmaceuticals was formed to concentrate on the development of novel therapeutic proteins for the treatment of metabolic disorders. In December 2010, Diartis Pharmaceuticals acquired the VRS-859 program from Versartis, Inc.


Date Type Amount Investors Valuation
02/01/11 Other Unknown Index Ventures, Amunix Inc. Unknown